Recruiting

Exploring Virtual Reality Adventure Training Exergaming

The current project aims to design and implement an 8-week Virtual Reality Adventure Therapy Exergaming (V-RATE) intervention focused on women veterans. A randomized controlled trial using a repeated measure design with a 1-month follow-up assessment will be employed to examine effects on physical and mental health outcomes.

ClinicalTrials.gov IDNCT05563805

PhaseNA

Enrollment40

SponsorThe University of Texas at Arlington

Age18 Years

SexFEMALE

I'm interested View official listing

Conditions studied

Physical Activity, Sedentary Behavior, Depression, Cognitive Function, Post Traumatic Stress Disorder, Quality of Life, Anxiety

About this study

Interventions

Device: Virtual Reality-based physical activity intervention — The V-RATE intervention will be delivered through a 360-degree non-mobilized treadmill in a university clinical laboratory for 6-8-weeks (1-2 days/week, 30 minutes/session) totaling 6 sessions. The V-RATE program will be focused on creating a safe and immersive environment supportive of physical activity. The treadmill enables an individual can walk and run at self-paced speed, moving in 360-degrees (i.e., forwards, sideways, and backwards) without risk of falling. The core feature of the self-paced treadmill is a concave walking platform with an adjustable waist hardness that enables a safe, smooth, natural gait while adults with elevated BMI engage in an immersive walking and running motion. During the V-RATE intervention, participants will self-pace their locomotor action (walking/running/bending/ jumping) while they wear the VR headset and experience immersive VR adventure games using the Omniverse VR system.

Primary outcomes

Change in depression from baseline to week 6-8 and one-month follow-up (Week 12) (Baseline, Week 6-8, Week 12)

Eligibility information

Inclusion Criteria: 1. Are between the ages of 18 and 45 2. Identify as a U.S. military veteran 4\. Normal vision (no colorblindness) Exclusion Criteria: 1. Unable to walk independently (e.g., use of any mobility assistive device such as brace, wheelchair, cane, crutch, walker, knee scooter) 2. Self-reported joint problem that limits mobility (e.g., arthritis or other condition that would prevent participation) or ongoing orthopedic injury 3. Self-reported pregnancy or suspicion of pregnancy 4. Self-reported motor disorder or impaired sense of motion or balance (such as Parkinsonism) 5. Self-reported color blindness 6. Self-reported neurological or cognitive disorder (e.g., TBI, history of seizure) 7. Self-reported cardiac surgery or any ongoing cardiovascular issues preventing participation or physical activity.

Study locations

University of Texas at Arlington, Arlington, Texas 76019 United States

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.